Clinical Trials Directory

Trials / Terminated

TerminatedNCT04119596

Study of the Genome, Gut Metagenome and Diet of Patients With Incident Parkinson's Disease

Status
Terminated
Phase
Study type
Observational
Enrollment
138 (actual)
Sponsor
Atlas Biomed · Industry
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

A case-control study to identify microbiome and genetic differences between healthy subjects and patients with incident Parkinson's disease.

Detailed description

Two groups of subjects - one including healthy individuals and the other - treatment-naive patients with incident Parkinson's disease - will fill in the food frequency questionnaire, SF-36 questionnaire, HADS questionnaire and the physical activity questionnaire. All subjects must have 0-3 points on Hoehn and Yahr scale and more than 22 points on MoCA scale. DNA microarray genotyping will be used to process the DNA samples of the participants. The data on the composition of the participants' gut microbiota will be obtained through 16S rRNA sequencing of their stool samples.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST16S rRNA gene sequencingTaking a stool sample for gut microbiome DNA sequencing
GENETICDNA-microarray genotypingTaking a saliva sample for genotyping

Timeline

Start date
2020-09-01
Primary completion
2022-02-01
Completion
2022-02-25
First posted
2019-10-08
Last updated
2022-07-21

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04119596. Inclusion in this directory is not an endorsement.